• WellPoint WLP reported estimate-topping third quarter earnings of $1.74 a share, up from Zacks estimates of $1.58, on revenues of $14.33 billion, above Zacks estimates of $14.22 billion
• Aetna AET topped projections with third quarter results of $0.84 a share, up from Zacks estimates of $0.67, on better-than-expected revenues of $8.54 billion, up from Zacks estimates of $8.33 billion
• Time Warner TWX posted better-than-estimated third-quarter earnings of $0.62 a share, up from Zacks projections of $0.53, on inline revenues of $6.4 billion
• CVS Caremark CVS reported inline third quarter earnings of $0.65 adjusted on revenues of $23.9 billion
• Qwest Communications Q posted third-quarter earnings of $0.11, above Zacks estimates of $0.09, on inline revenues of $2.9 billion
• RR Donnelley RRD topped by a penny with third quarter earnings of $0.44 on revenues of $2.49 billion, below Zacks estimates of $2.53 billion
• BlackRock BLK reported plans for a 42 million share secondary offering with 34.5 million shares being sold by Bank of America BAC and 7.5 million being sold by PNC Financial PNC. None of the proceeds will accrue to BlackRock
• Wynn WYNN reported inline results of $0.39, below Zacks estimates of $0.41, on revenues of $1 billion. The firm also declared an $8 per share dividend
• Goldman Sachs GS upgraded BP BP from "neutral" to "buy"
• Agrium AGU reported an earnings miss with results at $0.70 versus Zacks estimates of $0.89, on inline revenues of $2.01 billion
AETNA INC-NEW (AET): Free Stock Analysis Report
AGRIUM INC (AGU): Free Stock Analysis Report
BLACKROCK INC (BLK): Free Stock Analysis Report
BP PLC (BP): Free Stock Analysis Report
CVS CAREMARK CP (CVS): Free Stock Analysis Report
GOLDMAN SACHS (GS): Free Stock Analysis Report
PNC FINL SVC CP (PNC): Free Stock Analysis Report
QWEST COMM INTL (Q): Free Stock Analysis Report
DONNELLEY (RR) (RRD): Free Stock Analysis Report
TIME WARNER INC (TWX): Free Stock Analysis Report
WELLPOINT INC (WLP): Free Stock Analysis Report
WYNN RESRTS LTD (WYNN): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.